Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer
NCT01738815
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
43
Enrollment
OTHER
Sponsor class
Conditions
Hematuria
Bladder Cancer
Interventions
DRUG:
Valproic Acid
Sponsor
State University of New York - Upstate Medical University